Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Predictiemodel biedt handvat voor follow-up van barrettslokdarm
sep 2022 | Endoscopie, Maag-darm-leveroncologie